abnormal nitric oxide homeostasis, abnormal osteoblast physiology, abnormal osteoclast morphology, abnormal respiratory electron transport chain, abnormal skeleton physiology, abnormal vascular wound healing, abnormal vasodilation, abnormal white adipose tissue morphology, cardiac hypertrophy, decreased bone mass, decreased bone ossification, decreased bone trabecula number, decreased circulating adiponectin level, decreased circulating osteocalcin level, decreased fatty acid beta-oxidation, decreased food intake, decreased insulin secretion, decreased osteoblast cell number, decreased susceptibility to induced hypothermia, decreased systemic arterial blood pressure, decreased total fat pad weight, decreased trabecular bone volume, decreased ventricle muscle contractility, dilated heart left ventricle, fused podocyte foot processes, homeostasis/metabolism phenotype, increased bone mass, increased bone ossification, increased bone strength, increased carbon dioxide production, increased circulating adiponectin level, increased circulating glucose level, increased circulating osteocalcin level, increased compact bone thickness, increased core body temperature, increased energy expenditure, increased liver triglyceride level, increased noradrenaline level, increased osteoblast cell number, increased oxygen consumption, increased percent body fat/body weight, increased sensitivity to induced morbidity/mortality, increased susceptibility to diet-induced obesity, increased systemic arterial systolic blood pressure, increased total body fat amount, increased trabecular bone volume, increased vascular endothelial cell adhesion, liver/biliary system phenotype, maternal effect, muscle phenotype, oxidative stress, pulmonary vascular congestion, skeleton phenotype, vascular restenosis